Great company with great benefits and smart people, painful to be a part of Roche and Big Pharma now. - Director Genentech Employee Review

3.0
Jul 6, 2015
Recommend
CEO approval
Business Outlook

Pros

Great benefits, really smart people, great mission at Genentech. People focused and we know how to celebrate. Employee development is a priority and is funded.

Cons

Hard to be part of Roche and Big Pharma now. Next quarter's EPS feels more important than doing the logical thing that better prepares us for the future. Basel is the center of our world now, make no mistake. Gender bias is real, and much worse in Basel. Women and minorities slowly suffer from a thousand cuts.

Explore other reviews about Genentech

5.0
Jul 8, 2026
Recommend
CEO approval
Business Outlook

Pros

Great culture and work environment.

Cons

PhD is necessary oftentimes for advancement.

3.0
May 7, 2026
Recommend
CEO approval
Business Outlook

Pros

Genentech's origin story and mission are genuinely inspiring — few companies can point to such a meaningful historical arc in medicine. Patient engagement is taken seriously and feels authentic, not performative. The campus is beautiful and the culture has real warmth.

Cons

DDA is operating with significant gaps. First, the foundational data infrastructure is not mature enough to support the ambitions being set for the team. Second, the measurement culture has gotten ahead of the methodology, and no one in a position of authority seems to be asking hard questions about whether the numbers actually mean what they're being presented as meaning. Third, some management feel disconnected from the work itself, lacking the knowledge, hands-on experience, or relevant credentials. Individually any one of these would be manageable. Together these create an environment where it's hard to do rigorous work, rather work is performative, and be recognized for it.

3
See reviews by: Helpful|Rating|Date|All